Publishing Details
Contact & Outreach
About This Podcast
Explore Statistics
Recent Episodes
AI Powered Multiomics: Joachim Schmid on Data Analysis at Illumina
In this episode, Theral Timpson dives into the burgeoning field of multiomics and its massive data challenges with a veteran of digital pathology, Joachim Schmid. Schmid was recently appointed as…
The Genomic Revolution Transforming Public Health in Africa with Next-Generation Sequencing (NGS) with Professor Martin Nyaga
In this episode of the Illumina Genomics Podcast Illumina’s Amadou Gueye, Marketing Lead for the Middle East & Africa speaks to Professor Martin Nyaga, Head of the Next Generation Sequencing…
Illumina Scales Variant Calling and Genome Interpretation to Improve Gaps in Genetic Testing
In this podcast, Mendelspod’s Theral Timpson is joined by Sam Strom, a principal scientist at Illumina with a background in clinical testing. In this interview, Sam addresses two of the big…
How Do You Train Genomics AI? On Natural Selection Itself, Says VP of Illumina's AI Lab, Kyle Farh
In this podcast, Mendelspod’s Theral Timpson speaks to Kyle Farh, VP and distinguished scientist leading Illumina’s Artificial Intelligence Lab. Farh says the company began the AI lab seven years…
Two Industry Leaders on the Growing Complexity of Genomic Cancer Data
In this podcast, Mendelspod’s Theral Timpson speaks to Cara Statz from JAX and Erica Schnettler from Illumina about how their combined technologies are helping researchers and oncologists deal with…
Does finding a rare mutation accomplish anything?
Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a KIF5B-RET fusion by comprehensive genomic…
Clinical utility of ctDNA testing in lung cancer
Atocha Romero, PharmD, PhD, explains the value of liquid biopsy-based comprehensive genomic profiling. Dr. Romero provides an overview of the results of the NADIM II clinical trials and discusses…
ctDNA-guided treatment in colorectal cancer
Jeanne Tie, MD, discusses the DYNAMIC trial and areas of unmet needs for minimal residual disease (MRD) to become the standard of care for patients with colorectal cancer. The DYNAMIC trial showed…
Liquid biopsy NGS in cancer care
Pashtoon Kasi, MD, MS, explains how liquid biopsy next-generation sequencing (NGS)-based testing can benefit cancer patients. Dr. Kasi presents four colorectal cancer patient cases for whom…
Genetic counselling in an era of prenatal screening, tools to support patient informed consent
Listen to Genetic Counsellors Katie Ellis and Patricia Winters, Illumina discuss how more resource-efficient counselling methods are needed to support patient informed consent for genetic testing…
Testing for NTRK Fusions
Vivek Subbiah, MD, explains how patients with rare and common tumors can benefit from next generation sequencing (NGS)-based testing for NTRK gene fusions. He presents the case of a patient who…
Homologous Recombination Deficiency (HRD) Testing in Ovarian Cancer
Isabelle Ray-Coquard, MD, PhD, explains how comprehensive genomic profiling (CGP) simultaneously provides HRD and BRCA status in ovarian cancer patients. She presents the case of a patient who…
Pharmacogenomics: Barriers and Opportunities to Implementation
Dr. Ronald Leopold discusses implementation of pharmacogenomic screening in the healthcare industry. The conversation explores barriers to pharmacogenomic (PGx) program adoption, the future of…
The Impact of Pharmacogenomics on Precision Medicine
Why does a medication effectively “cure” one patient while having little to no effect, or worse, an adverse effect, on another? The answer may be found in our genome. Pharmacogenomics research aims…
Metagenomics in the Time of Covid-19: Emerging Pathogens
Robert Schlaberg and Lauge Farnaes from IdByDNA join us to talk about the evolution of metagenomics technology. The is the second half of their interview, where the focus shifts towards the…
Metagenomics in the Time of Covid-19: Clinical Metagenomics
Robert Schlaberg and Lauge Farnaes from IdByDNA join us in a two-part interview to talk about the evolution of metagenomics technology. In the first part of this interview, the discussion focuses on…
Genomic Surveillance and Testing for SARS-CoV-2
Christopher Mason from Weill Cornell Medicine discusses his multifaceted approach to the urgent need for testing when the COVID-19 pandemic broke out in early 2020. Chris also discusses finding from…
Exploring the Genomic Diversity of Africa
Although Africa is the continent with the highest amount of genetic diversity, it is underrepresented in global genomic databases. H3Africa is one of several initiatives, founded in 2010, that…
Developmental Biology Meets Immunotherapy
Although most developmental genes are silenced in adult somatic cells, some can be reactivated in cancer cells and promote tumor growth. Listen to Dr. Guo-Liang Chew of the Cancer Science Institute…
Genomics and the End of the Diagnostic Odyssey
Whole genome sequencing can help diagnose genetic diseases in days and holds the promise of helping parents avoid months or years of inconclusive tests. Listen to Dr. Vandana Shashi of Duke…
Frequently Asked Questions
Illumina Genomics Podcast has published 86 episodes since March 2017, covering topics in Life Sciences, Science.
Illumina Genomics Podcast is currently dormant with new episodes weekly. Average episode length is 22m.
Sign up on Grep.FM to access contact details for Illumina Genomics Podcast, including email and social media links.
